| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4879378
Max Phase: Preclinical
Molecular Formula: C22H20N8O
Molecular Weight: 412.46
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccc(-c4cn[nH]c4)cc3[nH]2)n1
Standard InChI: InChI=1S/C22H20N8O/c1-13(2)30-12-25-29-21(30)17-4-3-5-20(27-17)28-22(31)19-9-15-7-6-14(8-18(15)26-19)16-10-23-24-11-16/h3-13,26H,1-2H3,(H,23,24)(H,27,28,31)
Standard InChI Key: KECOPANJJUYUCT-UHFFFAOYSA-N
Associated Targets(Human)
Mitogen-activated protein kinase kinase kinase 5 1965 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 412.46 | Molecular Weight (Monoisotopic): 412.1760 | AlogP: 4.04 | #Rotatable Bonds: 5 |
| Polar Surface Area: 117.17 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.66 | CX Basic pKa: 2.36 | CX LogP: 2.74 | CX LogD: 2.74 |
| Aromatic Rings: 5 | Heavy Atoms: 31 | QED Weighted: 0.40 | Np Likeness Score: -1.80 |
References
| 1. Hou S, Yang X, Tong Y, Yang Y, Chen Q, Wan B, Wei R, Wang Y, Zhang Y, Kong B, Huang J, Chen Y, Lu T, Hu Q, Du D.. (2021) Structure-based discovery of 1H-indole-2-carboxamide derivatives as potent ASK1 inhibitors for potential treatment of ulcerative colitis., 211 [PMID:33360793] [10.1016/j.ejmech.2020.113114] |
Source
Source(1):